Paola Castellani, MD

Trials

Studies that name Paola Castellani, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:24 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06503770 · A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation

  Zambon SpA · completed · Bronchiolitis Obliterans Syndrome · study director
• Ph2
  NCT04107675 · A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)

  Zambon SpA · terminated · Bronchiolitis Obliterans Syndrome (BOS), GVHD, Chronic, Stem Cell Transplant Complications · study director
• Ph3
  NCT03657342 · Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

  Zambon SpA · completed · Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection · study director
• Ph3
  NCT03656926 · Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

  Zambon SpA · completed · Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection · study director
• Ph3
  NCT03460704 · Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

  Zambon SpA · terminated · Non Cystic Fibrosis Bronchiectasis · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.